Armistice Capital Reduces Stake in Avanos Medical, Inc. to 4.3%

On May 15, 2026, Armistice Capital, LLC and Steven Boyd filed a Schedule 13G/A (Amendment No. 2) regarding their holdings in Avanos Medical, Inc. (AVNS). The filing reports that as of March 31, 2026, the reporting persons beneficially own 2,000,000 shares of Common Stock, representing a 4.3% ownership stake in the company. This indicates a decrease in ownership to below the 5% threshold, as the previous filing status is noted at 0% in the supplemental data but the amendment number suggests a reduction from a prior reportable position. Armistice Capital, LLC serves as the investment manager for the Armistice Capital Master Fund Ltd., which is the direct holder of the shares. Steven Boyd, as the managing member of Armistice Capital, shares voting and dispositive power over these securities. The filing specifies that the shares were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. Consequently, the filers have checked the box indicating they now own 5% or less of the class of securities.